Currently Viewing:
Newsroom
Currently Reading
What We're Reading: Alabama Abortion Protests; House Equality Act; Rising Suicide Rates Among Girls
May 20, 2019 – AJMC Staff
Concurrent Decline in FVC, Walking Test More Likely Associated With Disease Progression in IPF
May 18, 2019 – Samantha DiGrande
Providing Pain Relief for Patients With Bone Metastases
May 18, 2019 – Laura Joszt
Opicapone Can Increase Length of ON-Periods in Patients With Parkinson Disease
May 18, 2019 – Wallace Stephens
Dysregulated Energy Production in Stem Cells Implicated in Fanconi Anemia
May 18, 2019 – Allison Inserro
Study Examines Effects of Alcohol, HIV, HCV on Immune System Activation
May 18, 2019 – Wallace Stephens
First-in-Human Study of Dual Inhibitor Licogliflozin Showed Significant Weight Loss in Obese Patients
May 17, 2019 – Mary Caffrey
Researchers Identify Potential Cause of Relapses in MS
May 17, 2019 – Samantha DiGrande
Researchers Examine Metabolic Effects of Ruxolitinib
May 17, 2019 – Allison Inserro

Flavonoid-Rich Cocoa Improved Fatigue by 45% in Patients With RRMS

Samantha DiGrande
A recent study sought to determine the impact of flavonoids on fatigue in relapsing and remitting multiple sclerosis (RRMS).
A recent study sought to determine the impact of flavonoids on fatigue in relapsing and remitting multiple sclerosis (RRMS).

Nine out of 10 people with multiple sclerosis experience fatigue, which can be extremely difficult to treat and have adverse effects on health and quality of life. Dark chocolate containing 70% to 85% cocoa solids is well known for its high antioxidant and flavonoid content and has been shown in a previous small randomized controlled pilot study to suggest an increase in quality of sleep and reduction in fatigue.

Researchers in this trial enrolled 40 patients recently diagnosed with RRMS in a parallel, randomized, double-blind, placebo-controlled trial in order to analyze the feasibility and efficacy of a flavonoid intervention. Patients were randomized to a high (n = 19) or low (n = 21) flavonoid groups.

Participants were provided a cocoa beverage mixed with heated rice milk by the lead researcher at baseline and at week 3, and they were asked to consume the drink in their homes daily. The beverage was consumed after an overnight fast at the same time each morning. After the beverage was consumed, participants were instructed to wait 30 minutes before eating any other food or beverage and/or take their medication.

Throughout the 6-week intervention participants were asked to rate their level of fatigue on a numerical scale from 1 to 10 (10 being the worst). Patients rated their level of fatigue 3 times per day for 6 weeks. Fatigability was measured at baseline and week 6 using a 6-minute walk test.

The study authors found that adherence to the intervention was 100% (19/19) in the intervention group, and 90% (19/21) in the control group. The relative risk for those who responded and therefore had improved fatigue in the intervention group (11 of 19 responders) compared with the control group (8 of 20 responders) was 1.45. Additionally, there was a moderate effect for distance walked in 6 minutes (0.45, 95% CI 0.18 to 1.07) between the groups with the intervention demonstrating a larger increase in the meters walked in 6 minutes after the intervention.

In total, those drinking the high flavonoid version showed a 45% improvement in subjectively assessed fatigue and an 80% improvement in walking speed. “A full evaluation including wider geography, longer follow-up, and cost effectiveness is now indicated. This technology has the potential to be implemented in the UK and worldwide, alongside other rehabilitation measures including exercise, DMTs [disease modifying treatments] and physiotherapy,” wrote the authors.

Reference

Coe S, Cossington J, Collett J, et al. A randomized double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosis [published online March 4, 2019]. BMJ. doi: 10.1136/jnnp-2018-319496.

Related Articles

Real-World Study Finds Better Outcomes in MS After Early Intensive Therapy
What Is the Smallest Change in Arm Function That Patients With MS Find Meaningful?
Vitamin B12 and B9 Supplements Increase QOL in Patients with RRMS
Variables Predict Patients With MS at Risk of Job Loss Who Can Benefit From Interventions
 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up